Bruno Julianne
SEC CIK 2019645 · EDGAR
BoughtSold
Most active insiders at DMRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schambye Hans T. | CEO, Dir | — | $15.0K |
| 2 | Winslow Garrett | GC | — | $12.8K |
| 3 | Firmani Lori | CFO | — | $2,890 |
| 4 | Sattarzadeh Sherwin | COO | — | — |
| 5 | Bruno Julianne | Dir | — | — |
| 6 | Hewes L. Becker | Chief Medical Off | — | — |
| 7 | Fairmount Healthcare Fund II L.P. | 10% | — | — |
| 8 | Jarrett Jennifer | See Remarks, Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-12 | 2026-02-09 | DMRA | Damora Therapeutics, Inc. | Bruno Julianne | Dir | M - OptEx | $0.00 | +129.0K | 137.0K | +1,606% | $0 |
| D | 2025-03-24 | 2025-03-20 | CRSP | CRISPR Therapeutics AG | Bruno Julianne | COO | M - OptEx | — | +3,750 | 12.3K | +44% | — |
| D | 2025-03-24 | 2025-03-21 | CRSP | CRISPR Therapeutics AG | Bruno Julianne | COO | S - Sale+OE | $41.23 | -1,714 | 10.5K | -14% | -$70.7K |
| DM | 2025-03-12 | 2025-03-10+ | CRSP | CRISPR Therapeutics AG | Bruno Julianne | COO | M - OptEx | — | +2,834 | 8,698 | +48% | — |
| DM | 2025-03-12 | 2025-03-11+ | CRSP | CRISPR Therapeutics AG | Bruno Julianne | COO | S - Sale+OE | $42.54 | -1,388 | 8,508 | -14% | -$59.0K |
| D | 2025-02-19 | 2025-02-18 | CRSP | CRISPR Therapeutics AG | Bruno Julianne | COO | M - OptEx | — | +650 | 7,395 | +10% | — |
| D | 2025-02-19 | 2025-02-19 | CRSP | CRISPR Therapeutics AG | Bruno Julianne | COO | S - Sale+OE | $52.80 | -333 | 7,062 | -5% | -$17.6K |
| D | 2024-06-24 | 2024-06-21 | CRSP | CRISPR Therapeutics AG | Bruno Julianne | COO | S - Sale+OE | $56.09 | -3,366 | 6,745 | -33% | -$188.8K |
| D | 2024-06-24 | 2024-06-20 | CRSP | CRISPR Therapeutics AG | Bruno Julianne | COO | M - OptEx | — | +7,000 | 10.1K | +225% | — |
Purchase Sale Sale after option exercise All abbreviations